Microsystem for Heart and Stem Cells Processing

A special issue of Biosensors (ISSN 2079-6374). This special issue belongs to the section "Biosensors and Healthcare".

Deadline for manuscript submissions: closed (15 April 2021) | Viewed by 9422

Special Issue Editor


E-Mail Website
Guest Editor
Chair of Medical Biotechnology, Faculty of Chemistry, Warsaw University of Technology, 00-661 Warsaw, Poland
Interests: development of the microsystems used in cellular engineering (2D and 3D culture and analysis of carcinoma, heart, and stem cells) and in biotechnology (micro-PCR system); modification of materials, i.e., poly(dimethylsiloxane) used for lab-on-a-chip fabrication

Special Issue Information

Dear Colleagues,

Cardiovascular diseases (CVDs) are the most common cause of death around the world. CVDs damage cardiomyocytes (CMs), and as a result, these cells lose their ability to renew. The use of a treatment method is determined based on the type and state of disease. Recently, regenerative medicine based on stem cells (SCs) seems to have had an important role in medicine, especially in cardiology.

To define the proper parameters for cell regeneration and effective therapy, studies under conditions as close as possible to native tissue should be performed. Conventional culture models do not fulfill such requirements. Perfusion lab-on-a-chip systems, mimicking tissue features, seem to be a suitable tool used for cell study. Microsystems used to culture cardiac and stem cells, as well as for the creation of vascularization, stem cell differentiation, and drug toxicity cell study, can be a helpful method to study diseases, especially CVDs.

Original papers focusing on achievements in the study of cardiac, stem, and vascular cells in microscale, new technologies of microsystem fabrication, as well as review reports on recent developments in the field will be considered for publication. This Special Issue entitled "Microsystem for Heart and Stem Cell Processing" is dedicated to biologists, engineers, microfluidic specialists, cell culture experts, cardiologists, and other experts connecting with this research field.

Prof. Dr. Elzbieta Jastrzebska
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biosensors is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Lab-on-a-chip
  • Heart-on-a-chip
  • Vascularization
  • Stem cells
  • Microfluidic
  • Cell differentiation
  • Cardiovascular diseases
  • Toxicology

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 4882 KiB  
Article
Thermoplastic Elastomer (TPE)–Poly(Methyl Methacrylate) (PMMA) Hybrid Devices for Active Pumping PDMS-Free Organ-on-a-Chip Systems
by Mathias Busek, Steffen Nøvik, Aleksandra Aizenshtadt, Mikel Amirola-Martinez, Thomas Combriat, Stefan Grünzner and Stefan Krauss
Biosensors 2021, 11(5), 162; https://0-doi-org.brum.beds.ac.uk/10.3390/bios11050162 - 19 May 2021
Cited by 18 | Viewed by 5973
Abstract
Polydimethylsiloxane (PDMS) has been used in microfluidic systems for years, as it can be easily structured and its flexibility makes it easy to integrate actuators including pneumatic pumps. In addition, the good optical properties of the material are well suited for analytical systems. [...] Read more.
Polydimethylsiloxane (PDMS) has been used in microfluidic systems for years, as it can be easily structured and its flexibility makes it easy to integrate actuators including pneumatic pumps. In addition, the good optical properties of the material are well suited for analytical systems. In addition to its positive aspects, PDMS is well known to adsorb small molecules, which limits its usability when it comes to drug testing, e.g., in organ-on-a-chip (OoC) systems. Therefore, alternatives to PDMS are in high demand. In this study, we use thermoplastic elastomer (TPE) films thermally bonded to laser-cut poly(methyl methacrylate) (PMMA) sheets to build up multilayered microfluidic devices with integrated pneumatic micro-pumps. We present a low-cost manufacturing technology based on a conventional CO2 laser cutter for structuring, a spin-coating process for TPE film fabrication, and a thermal bonding process using a pneumatic hot-press. UV treatment with an Excimer lamp prior to bonding drastically improves the bonding process. Optimized bonding parameters were characterized by measuring the burst load upon applying pressure and via profilometer-based measurement of channel deformation. Next, flow and long-term stability of the chip layout were measured using microparticle Image Velocimetry (uPIV). Finally, human endothelial cells were seeded in the microchannels to check biocompatibility and flow-directed cell alignment. The presented device is compatible with a real-time live-cell analysis system. Full article
(This article belongs to the Special Issue Microsystem for Heart and Stem Cells Processing)
Show Figures

Graphical abstract

14 pages, 2488 KiB  
Article
Study of Stem Cells Influence on Cardiac Cells Cultured with a Cyanide-P-Trifluoromethoxyphenylhydrazone in Organ-on-a-Chip System
by Anna Kobuszewska, Dominik Kolodziejek, Michal Wojasinski, Tomasz Ciach, Zbigniew Brzozka and Elzbieta Jastrzebska
Biosensors 2021, 11(5), 131; https://0-doi-org.brum.beds.ac.uk/10.3390/bios11050131 - 23 Apr 2021
Cited by 7 | Viewed by 3068
Abstract
Regenerative medicine and stem cells could prove to be an effective solution to the problem of treating heart failure caused by ischemic heart disease. However, further studies on the understanding of the processes which occur during the regeneration of damaged tissue are needed. [...] Read more.
Regenerative medicine and stem cells could prove to be an effective solution to the problem of treating heart failure caused by ischemic heart disease. However, further studies on the understanding of the processes which occur during the regeneration of damaged tissue are needed. Microfluidic systems, which provide conditions similar to in vivo, could be useful tools for the development of new therapies using stem cells. We investigated how mesenchymal stem cells (MSCs) affect the metabolic activity of cardiac cells (rat cardiomyoblasts and human cardiomyocytes) incubated with a potent uncoupler of mitochondrial oxidative phosphorylation under microfluidic conditions. A cyanide p-trifluoromethoxyphenylhydrazone (FCCP) was used to mimic disfunctions of mitochondria of cardiac cells. The study was performed in a microfluidic system integrated with nanofiber mats made of poly-l-lactid acid (PLLA) or polyurethane (PU). The microsystem geometry allows four different cell cultures to be conducted under different conditions (which we called: normal, abnormal—as both a mono- and co-culture). Metabolic activity of the cells, based on the bioluminescence assay, was assessed in the culture’s performed in the microsystem. It was proved that stem cells increased metabolic activity of cardiac cells maintained with FCCP. Full article
(This article belongs to the Special Issue Microsystem for Heart and Stem Cells Processing)
Show Figures

Figure 1

Back to TopTop